Meningococcal polysaccharide group A - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19A"

Product details Supply Impact Dates Further Details
MENACTRA meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine, solution for intramuscular injection
AUST R: 168403
Active ingredients:
Diphtheria toxoid
Meningococcal polysaccharide group A
Meningococcal polysaccharide group C
Meningococcal polysaccharide group W135
Meningococcal polysaccharide Group Y

Sponsor:
Sanofi-Aventis Australia Pty Ltd

Phone:
1800818806

From
11 Feb 2019
to
31 May 2019

Status:
Current

Patient impact:
Medium

Availability:
Limited Availability

Reason:
Unexpected Increase in Demand

Related information:

TGA Management Actions:
21/02/19 Sponsor is working to expedite the next shipment. The sponsor is closely controlling the supply.